Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)

被引：0

作者：

Kohlbrenner, Katharina ^{[1
]}

Galuschek, Norbert ^{[1
]}

Fabarius, Alice ^{[1
]}

Reiser, Marcel

Fenchel, Klaus ^{[2
]}

Esseling, Eva ^{[3
]}

Goehler, Thomas ^{[4
]}

Geer, Thomas ^{[5
]}

Depenbusch, Reinhard ^{[6
]}

Azeh, Ivo Talah ^{[7
]}

Engel, Erik ^{[8
]}

Hansen, Richard ^{[9
]}

Lindemann, Hans-Walter ^{[10
]}

Anhuf, Juergen ^{[11
]}

Jehner, Paul ^{[12
]}

Abu-Samra, Maisun ^{[13
]}

Ritter, Markus ^{[14
]}

Gattermann, Norbert ^{[15
]}

Pelz, Henning ^{[16
]}

Fuxius, Stefan ^{[17
]}

Oswald, Burkhard ^{[18
]}

Baerlocher, Gabriela M. ^{[19
,20
]}

Brummendorf, Tim H. H. ^{[21
]}

Heim, Dominik ^{[22
]}

le Coutre, Philipp ^{[23
]}

Burchert, Andreas ^{[24
]}

Niederwieser, Dietger ^{[25
]}

Tesch, Hans ^{[26
]}

Hofmann, Wolf-Karsten ^{[1
]}

Hochhaus, Andreas ^{[27
]}

Hehlmann, Ruediger ^{[28
]}

Saussele, Susanne ^{[1
]}

机构：

[1] Heidelberg Univ, Med Fak Mannheim, Med Klin 3, Mannheim, Germany

[2] Onkol Praxisklin Hamatol Onkol & Gerinnungsstorun, Saalfeld, Germany

[3] Univ Klinikum Munster, Med Klin A, Munster, Germany

[4] Onkozentrum Dresden, Dresden, Germany

[5] Diakonie Klinikum, Innere Med 3, Schwabisch Hall, Germany

[6] Onkol Gemeinschaftspraxis Dres Depenbusch, Schutt and Sonnenberg, Gutersloh, Germany

[7] Onkol Gemeinschaftspraxis & Tagesklin Dres Med C, Gelsenkirchen, Germany

[8] Hamatol Onkol Praxis Altona HOPA, Hamburg, Germany

[9] Onkol Gemeinschaftspraxis Dres Hansen & Reeb, Kaiserslautern, Germany

[10] Katholisches Krankenhaus, Hamatol & Onkol, Hagen, Germany

[11] Onkol Duisburg Nord, Duisburg, Germany

[12] Onkol Praxis Moers, Moers, Germany

[13] Univ Klinikum Giessen & Marburg, Med Klin & Poliklin Hamatol 4, Giessen, Germany

[14] MVZ Sindelfingen, Onkol Praxis, Sindelfingen, Germany

[15] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany

[16] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany

[17] Onkol Schwerpunktpraxis Heidelberg, Heidelberg, Germany

[18] Onkol Schwerpunktpraxis Worms, Worms, Germany

[19] Univ Klin Hamatol, Inselspital Bern, Bern, Switzerland

[20] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland

[21] Univ Klinikum RWTH Aachen, Med Klin 4, Aachen, Germany

[22] Univ Spital Basel, Klin Hamatol, Basel, Switzerland

[23] Charite Univ Med Berlin, Campus Virchow Med Klin S Hamatol & Onkol, Berlin, Germany

[24] Univ Klinikum Giessen & Marburg, Hamatol Onkol & Immunol, Marburg, Germany

[25] Univ Klinikum Leipzig, Abt Hamatol & Internist Onkol, Leipzig, Germany

[26] Ctr Hamatol & Onkol Bethanien, Frankfurt, Germany

[27] Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany

[28] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy
Barber, Mary C.
Mauro, Michael J.
Moslehi, Javid
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 110 - 114
[42] Outcomes in Patients with Chronic Myeloid Leukemia (CML) Who Are Treated with Imatinib As Front Line Therapy
Sweet, Kendra L.
Al Ali, Najla H.
Lancet, Jeffrey E.
Creelan, Ben
Tinsley, Sara
Shah, Bijal D.
Zhang, Ling
Komrokji, Rami S.
Pinilla-Ibarz, Javier
BLOOD, 2012, 120 (21)
[43] How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
Murthy, Guru Subramanian Guru
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 1 - 6
[44] Increased dose of imatinib for suboptimal response in CML in chronic phase.: Results of the Spanish registry of chronic myeloid leukemia (RELMC)
Montero, L. F. Casado
Giraldo, P.
Massague, I.
De Paz, R.
Calle, C.
Fores, R.
Albizua, O.
Burgaleta, C.
Steegmann, J. L.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 249 - 250
[45] Molecular response of paediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
Dhara, Atanu
Mukhopadhyay, S.
Das, S.
Mukhopadhyay, A.
PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 444 - 445
[46] Understanding United States (US) Treatment Practices for the Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: A US Subgroup Analysis of the WORLD CML Registry.
Hermann, Robert
Miller, Carole B.
Catchatorian, Rosalind
Snyder, David S.
Ericson, Solveig G.
Zernovak, Oleg
Juma, Matthews A.
Cortes, Jorge E.
BLOOD, 2012, 120 (21)
[47] Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: An International Registry of Childhood Chronic Myeloid Leukemia (I-CML-Ped) Study
Millot, Frederic
Suttorp, Meinolf
Ragot, Stephanie
Leverger, Guy
Dalle, Jean-Hugues
Versluijs, Birgitta
Lausen, Birgitte
Borisevich, Marina
BLOOD, 2020, 136
[48] Concomitant or Sequential Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML): A Molecular and Clinical Survey
Said, Carla
Heimann, P.
Dessars, B.
Phong, Dinh
Cantiniaux, B.
Cantiniaux, B.
Meuleman, N.
Bron, D.
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : E34 - E34
[49] Asciminib As Initial Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)-H. Jean Khoury Cure CML Consortium Study
Atallah, Ehab L.
Visotcky, Alexis
Flynn, Kathryn E.
Zhang, Mei-Jie
Radich, Jerald P.
Yang, Jay
Oehler, Vivian G.
Tantravahi, Srinivas K.
Smith, B. Douglas Douglas
Ibarz, Javier Pinilla
Sweet, Kendra
Mauro, Michael
Druker, Brian J.
Thompson, James E.
Maldonado-Schmidt, Sonia
Baim, Arielle
Schiffer, Charles A.
Kota, Vamsi K.
Cortes, Jorge E.
BLOOD, 2022, 140 : 3885 - 3886
[50] Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV
Saussele, Susanne
Krauss, Marie-Paloma
Hehlmann, Ruediger
Lauseker, Michael
Proetel, Ulrike
Kalmanti, Lida
Hanfstein, Benjamin
Fabarius, Alice
Kraemer, Doris
Berdel, Wolfgang E.
Bentz, Martin
Staib, Peter
de Wit, Maike
Wernli, Martin
Zettl, Florian
Hebart, Holger F.
Hahn, Markus
Heymanns, Jochen
Schmidt-Wolf, Ingo
Schmitz, Norbert
Eckart, Michael J.
Gassmann, Winfried
Bartholomaeus, Andrea
Pezzutto, Antonio
Leibundgut, Elisabeth Oppliger
Heim, Dominik
Krause, Stefan W.
Burchert, Andreas
Hofmann, Wolf-Karsten
Hasford, Joerg
Hochhaus, Andreas
Pfirrmann, Markus
Mueller, Martin C.
BLOOD, 2015, 126 (01) : 42 - 49

← 1 2 3 4 5 →